# Batch Risk of Bias Eval Report

This report contains an audit trace: explicit extracted evidence, model-provided rationales, and label comparisons. It does not include hidden chain-of-thought.

- Studies: 5
- Domains: 25
- Accuracy: 13/25 (52.0%)

## Summary

| PMID | Study | Correct | Accuracy | Seconds |
|---|---|---:|---:|---:|
| 19487623 | King 2009 | 3/5 | 60.0% | 37.61 |
| 20579848 | Palacios 2009 | 1/5 | 20.0% | 37.86 |
| 21775755 | Ziegler 2011 | 3/5 | 60.0% | 48.55 |
| 22928960 | Houry 2012 | 3/5 | 60.0% | 39.21 |
| 23148458 | Sheridan 2012 | 3/5 | 60.0% | 41.21 |

## Error Types

- under-called_due_to_missing_or_underused_evidence: 6
- over-inferred_from_sparse_reporting: 3
- blinding_outcome_type_or_role_confusion: 2
- attrition_balance_or_missing_data_handling: 1

## 19487623 - King 2009

- Mode: hybrid
- Article chars: 24566
- Extraction context chars: 12006
- Total seconds: 37.61

### Methodology Extraction

- `randomization_method`: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).
- `allocation_concealment_method`: Not reported
- `blinding_participants`: Not reported
- `blinding_personnel`: Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated.
- `blinding_outcome_assessors`: The evaluating clinician monitored efficacy and was blinded to adverse events. Evaluating clinicians from all sites were trained to reliability on the CYBOCS-PDD, CGI-I, and Clinical Global Impressions, Severity of Illness Scale at the beginning and midpoint of the trial.
- `attrition_details`: 149 were randomized to receive citalopram (n=73) or placebo (n=76). Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent. For subjects who failed to complete all postrandomization assessments, the last observation was carried forward.
- `study_design`: Randomized, placebo-controlled parallel-group trial (individual RCT).
- `additional_notes`: Liquid citalopram was used and placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications. The trial was registered (NCT00086645) and conducted at 6 academic centers with a Data and Safety Management Board. All efficacy and safety analyses used the intent-to-treat principle.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |
| Allocation concealment | Unclear risk | Unclear risk | yes |  |
| Blinding of participants and personnel: All outcomes | Low risk | Low risk | yes |  |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: The trial explicitly describes use of permuted blocks with randomly varying block sizes (a random number–based method) stratified by site and age, which meets criteria for low risk of bias in random sequence generation.
- Model support: Quote: "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)." Comment: This description explicitly reports a random component to sequence generation (permuted block randomization with randomly varying block sizes), so sequence generation was probably done appropriately.
- GT support: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)
- Source context preview: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years). Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated. --- ## Methods --- ## Randomization and Blinding --- The primary analysis compared the proportion of subjects showing a positive response between groups using the χ2 test. For subjects who failed to complete...

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Unclear risk
- Match: True
- Model rationale: The study describes the randomization procedure but gives no information on how allocations were concealed from those enrolling participants. Without details (central allocation, sealed envelopes, pharmacy control), we cannot determine whether enrolment could foresee assignments, so risk of bias is unclear.
- Model support: Quote: "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)." Comment: Allocation concealment method not reported in the paper; no description of central randomization or use of sealed/opaque envelopes or pharmacy-controlled procedures is provided. Probably not reported, so insufficient information to judge.
- GT support: Details not provided
- Source context preview: ## Methods --- Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years). Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated. --- Two hundred forty-four of 331 participants screened by telephone were presumed eligible and were invited for a screening visit. Consent was obtained for 175 subjects, and 149 were randomized...

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: Placebo was matched to citalopram and masked clinicians conducted evaluations with separation of roles, indicating effective blinding of participants and personnel; thus performance bias is unlikely to have materially influenced outcomes.
- Model support: Quote: "Liquid citalopram was used and placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications." "Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated." Comment: Blinding of participants and key study personnel was implemented (placebo matched to active and use of masked clinicians). There is no indication blinding was broken. Probably done.
- GT support: Two masked clinicians met with participants during each scheduled evaluation
- Source context preview: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years). Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated. --- Two hundred forty-four of 331 participants screened by telephone were presumed eligible and were invited for a screening visit. Consent was obtained for 175 subjects, and 149 were randomized to receive...

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The study explicitly reports masked (blinded) evaluating clinicians for the efficacy outcomes, including the primary clinician-rated CGI-I and CYBOCS-PDD, and provides evidence of rater training and reliability, making it unlikely that outcome assessment was influenced by knowledge of allocation.
- Model support: Quote: "Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. Evaluating clinicians from all sites were trained to reliability on the CYBOCS-PDD, CGI-I, and Clinical Global Impressions, Severity of Illness Scale at the beginning and midpoint of the trial." Comment: Blinding of outcome assessment was ensured for the evaluating clinicians who rated the primary (CGI-I) and clinician-rated secondary (CYBOCS-PDD) outcomes; training and interrater reliability were established. Probably done.
- GT support: The evaluating clinician monitored efficacy and was blinded to AEs
- Source context preview: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years). Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated. --- The primary outcome measure was the CGI-I rated by the evaluating clinician. The CGI-I is a subscale scored from 1 (very much improved) to 7 (very much worse).23 A score of 4 reflects no change. Positive...

#### Incomplete outcome data: All outcomes

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: Attrition was moderate and roughly balanced between groups with similar reasons for withdrawal; handling used LOCF and authors state most participants completed the trial, making bias from incomplete outcome data unlikely to materially affect results.
- Model support: Quote: "Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent (Figure 1). For subjects who failed to complete all postrandomization assessments, the last observation was carried forward." Comment: Missing data were modest (overall ~17.4% non-completion), balanced across groups with similar reasons (adverse events and withdrawal), and were handled with last observation carried forward. Probably done: reasons for missingness appear unlikely to be related differentially to outcome and rates are similar across arms.
- GT support: LTFU citalopram: 13 withdrew, 1 due to serious AE; 8 AEs; 2 protocol violations; 2 consent withdrawn LTFU placebo: 13 withdrawn, 7 AEs; 1 protocol violation; 5 consent withdrawn
- Source context preview: The primary analysis compared the proportion of subjects showing a positive response between groups using the χ2 test. For subjects who failed to complete all postrandomization assessments, the last observation was carried forward. For comparison purposes, analyses were also performed among subjects who completed all assessments. A similar approach was followed for each secondary outcome. All analyses are performed using commercially available software (SAS version 9.1; SAS Institute, Cary, North Carolina). Unless otherwise specified, all statistical tests were performed at a 5% level of significance (2-sided). --- Two hundred forty-four of 331 participants screened by telephone were...


## 20579848 - Palacios 2009

- Mode: hybrid
- Article chars: 25127
- Extraction context chars: 12003
- Total seconds: 37.86

### Methodology Extraction

- `randomization_method`: Not reported
- `allocation_concealment_method`: Not reported
- `blinding_participants`: The trial is described as "randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial". (From Methods: "We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk...")
- `blinding_personnel`: Not reported
- `blinding_outcome_assessors`: "Measurements were taken ... by the CRC-trained personnel, who were blinded to the study treatments." (From Body composition measurements)
- `attrition_details`: Of the 46 subjects recruited, 10 did not qualify due to a calcium intake above 700 mg/d and 6 subjects retired before the initial visit. Therefore, 30 subjects were enrolled in the study. Five subjects dropped out from the study before the second visit; four females and one male. The reasons for not continuing in the study were as follows: one had medical reasons and four lost interest. Of the 25 subjects who completed the study, 20 were female and 5 were male. "There were no significant...
- `study_design`: "single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial"
- `additional_notes`: Interventions: three-arm parallel design (high dairy group, high elemental calcium group, or control group) for 21 weeks. Calcium supplement: 600 mg/d calcium carbonate (Delavau LLC). Control group received placebo tablet. Compliance monitored with monthly calendar, food records, FFQ, and 24-h recalls. Subjects instructed to maintain usual physical activity and isocaloric intake. Informed consent and IRB approval reported.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Unclear risk | Low risk / Not applicable | no | blinding_outcome_type_or_role_confusion |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk / Not applicable | yes |  |
| Incomplete outcome data: All outcomes | Low risk | Not applicable / Unclear risk | no | attrition_balance_or_missing_data_handling |

### Audit Details

#### Random sequence generation

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: The report only states that participants were "randomly assigned" but gives no description of the randomization procedure or any random component; per Cochrane criteria this lack of detail means risk of bias for sequence generation is unclear.
- Model support: Quote: "They were randomly assigned to one of the three treatments: high dairy group, high calcium group, and control." Comment: The paper states participants were "randomly assigned" but provides no details about the random sequence generation method (e.g., computer, random number table, coin toss). Therefore sequence generation is not described. Probably not reported.
- GT support: Comment: mail from Dr Palacios: "The random sequence was computer generated"
- Source context preview: There are several strengths and limitations of the study. Strengths of this study include the following: design, calcium dose, and compliance measures. The design of the study, a randomized, double-blinded (single-blinded for the high dairy group), placebo-controlled trial with two calcium sources without energy-restricted diets or exercise intervention, allowed studying the effects of calcium alone on body composition and serum lipids under their usual free-living conditions. The total dose aimed in the study (four dairy products servings for the high dairy group and 1200 mg/d for the high calcium group) are similar to the US Dietary Guidelines and US DRI. In addition, these doses are...

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: The article describes random assignment but gives no information on how allocations were concealed from enrolling investigators or participants (no description of central allocation, sealed envelopes, or equivalent). This lack of detail prevents assessment of whether selection bias could have occurred.
- Model support: Comment: The report states only that subjects "were randomly assigned to one of the three treatments: high dairy group, high calcium group, and control." No details are provided on the method used to conceal allocation (e.g., central randomization, sealed envelopes) or safeguards to prevent foreknowledge of assignments. Probably not reported.
- GT support: Comment: mail from Dr Palacios: "The random sequence was computer generated and the allocation concealment was performed centrally"
- Source context preview: Forty-six sedentary obese male and female adults, aged 22–50 y, were recruited for the study through flyers, local newspaper, and radio advertisements in the San Juan area in Puerto Rico. Following preliminary screening by telephone, volunteers were invited to the CRC for an orientation meeting. A detailed description of the study was provided and written consent forms were obtained from each subject. Study eligibility criteria included being 21–50 y old, obese (defined by a body mass index (BMI), of 30 kg/m2 or more [23]), absence of chronic conditions, not taking calcium supplements or taking any medication regularly (including birth control pills, weight-reducing pills, insulin,...

#### Blinding of participants and personnel: All outcomes

- Prediction: Unclear risk
- Ground truth: Low risk / Not applicable
- Match: False
- Model rationale: The paper explicitly notes mixed blinding (double-blind overall but single-blinded for the dairy group) and does not detail blinding of personnel or how participant blinding was maintained for the dietary (dairy) intervention; without clarity on who was blinded and the likelihood of unblinding, inability to assess impact on outcomes leads to an unclear risk judgment.
- Model support: Quote: "We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk..." Comment: The report states the trial was double-blind but specifies it was "single-blinded for the dairy group", and personnel blinding is not described; outcome assessors were blinded. It is unclear who (participants, personnel) were blinded for each comparison and whether blinding could have been broken. Probably not enough information to judge risk of performance bias.
- GT support: Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric...
- Source context preview: There are several strengths and limitations of the study. Strengths of this study include the following: design, calcium dose, and compliance measures. The design of the study, a randomized, double-blinded (single-blinded for the high dairy group), placebo-controlled trial with two calcium sources without energy-restricted diets or exercise intervention, allowed studying the effects of calcium alone on body composition and serum lipids under their usual free-living conditions. The total dose aimed in the study (four dairy products servings for the high dairy group and 1200 mg/d for the high calcium group) are similar to the US Dietary Guidelines and US DRI. In addition, these doses are...

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk / Not applicable
- Match: True
- Model rationale: The article explicitly states that CRC-trained personnel who performed measurements were blinded to study treatments, indicating outcome assessors were blinded and blinding unlikely to be broken, so risk of detection bias is low.
- Model support: Quote: "Measurements were taken ... by the CRC-trained personnel, who were blinded to the study treatments." Comment: Blinding of outcome assessment was explicitly reported for measurements (body composition etc.); therefore detection bias is unlikely. Probably done.
- GT support: Blind outcome assessors | Blind outcome assessors | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study." | Blind outcome assessors | Blind outcome assessors | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr. Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study."
- Source context preview: There are several strengths and limitations of the study. Strengths of this study include the following: design, calcium dose, and compliance measures. The design of the study, a randomized, double-blinded (single-blinded for the high dairy group), placebo-controlled trial with two calcium sources without energy-restricted diets or exercise intervention, allowed studying the effects of calcium alone on body composition and serum lipids under their usual free-living conditions. The total dose aimed in the study (four dairy products servings for the high dairy group and 1200 mg/d for the high calcium group) are similar to the US Dietary Guidelines and US DRI. In addition, these doses are...

#### Incomplete outcome data: All outcomes

- Prediction: Low risk
- Ground truth: Not applicable / Unclear risk
- Match: False
- Model rationale: Reasons for dropout were reported and seem unlikely related to true outcomes, dropouts were few (17%) and balanced description shows no significant differences between completers and non-completers, so attrition is unlikely to have materially biased the effect estimates.
- Model support: Quote: "Of the 46 subjects recruited, 10 did not qualify due to a calcium intake above 700 mg/d and 6 subjects retired before the initial visit. Therefore, 30 subjects were enrolled in the study. Five subjects dropped out from the study before the second visit; four females and one male. The reasons for not continuing in the study were as follows: one had medical reasons and four lost interest. There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who completed the study, 20 were female and 5 were male." Comment: Reasons for missing outcome data are reported and appear unrelated to the outcomes (one medical reason, four lost interest). Missing data are relatively small (5/30 = 17%) and authors state no significant differences between completers and non-completers....
- GT support: 20 participants randomised and 17 assessed | 20 participants randomised and 17 assessed | Quote from publication: "There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who completed the study, 20 were female and 5 were male. Within the ﬁve males, one was allocated to the high dairy group, two to the high calcium group, and two to the control group." Comment: attrition rates were 10% and 20% but relating to a small number of randomised participants (N = 10) in both groups | 20 participants randomised and 17 assessed | 20 participants randomised and 17 assessed | Quote from publication: "There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who...
- Source context preview: Forty-six sedentary obese male and female adults, aged 22–50 y, were recruited for the study through flyers, local newspaper, and radio advertisements in the San Juan area in Puerto Rico. Following preliminary screening by telephone, volunteers were invited to the CRC for an orientation meeting. A detailed description of the study was provided and written consent forms were obtained from each subject. Study eligibility criteria included being 21–50 y old, obese (defined by a body mass index (BMI), of 30 kg/m2 or more [23]), absence of chronic conditions, not taking calcium supplements or taking any medication regularly (including birth control pills, weight-reducing pills, insulin,...


## 21775755 - Ziegler 2011

- Mode: hybrid
- Article chars: 24371
- Extraction context chars: 12003
- Total seconds: 48.55

### Methodology Extraction

- `randomization_method`: Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six.
- `allocation_concealment_method`: The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.
- `blinding_participants`: randomized, double-blind, placebo-controlled... film-coated tablets containing 600 mg ALA ... or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance
- `blinding_personnel`: randomized, double-blind, placebo-controlled... The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.
- `blinding_outcome_assessors`: Experienced, trained, and certified (by P.J.D. and colleagues) physicians evaluated the NIS and NSC. The nerve conduction, quantitative sensory tests (QSTs), and autonomic tests were performed by trained and certified personnel (by P.A.L., W.J.L., P.J.D., and colleagues). All results were interactively evaluated by the Reading and Quality Assurance Centers (at Mayo Clinic and Health Partners).
- `attrition_details`: Not reported
- `study_design`: multicenter, randomized, double-blind, placebo-controlled, two-arm, 1:1 allocation ratio, parallel-group clinical trial
- `additional_notes`: The trial consisted of a 2-week screening phase, 6-week placebo run-in phase, 4-year double-blind phase, and 4-week washout phase. An interim analysis was performed as soon as the 2-year data of most subjects were available. The random allocation used undisclosed block size of six. Sealed envelopes were provided to investigators and monitor for emergency decoding.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Low risk | Low risk | yes |  |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | High risk | no | under-called_due_to_missing_or_underused_evidence |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial explicitly states a randomization list was generated by the Biostatistics Department and used block randomization, which describes a random component in sequence generation consistent with Low risk criteria.
- Model support: Quote: "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six." Comment: Probably done — a randomization list generated by a biostatistics department with block randomization indicates a random sequence (computer-generated or equivalent).
- GT support: Quote: "a randomization list was generated by the biostatistics department of the manufacturer of the study drug ..."
- Source context preview: Screened patients were assigned a unique five-digit number. Randomized patients were additionally assigned a four-digit randomization number at baseline. Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six. The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency. --- The Neurological Assessment of Thioctic Acid in Diabetic Neuropathy (NATHAN) 1 trial was a multicenter (36 centers in the U.S., Canada, and Europe [Supplementary Materials]), randomized,...

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: The report notes sealed envelopes for emergency unblinding, but gives no details on the envelope procedures or other central allocation methods; this insufficient detail means risk of selection bias due to allocation concealment is unclear.
- Model support: Quote: "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency." Comment: The use of sealed envelopes for emergency decoding is stated, but it is not described whether allocation was concealed from those enrolling participants (e.g. whether envelopes were sequentially numbered, opaque, and sealed and kept by an independent party) or whether central/randomization control was used. Therefore allocation concealment cannot be confirmed. Probably not fully reported.
- GT support: Quote: "a randomization list was generated by the biostatistics department of the manufacturer of the study drug, at distance of the centers the study took place"; "the random allocation was balanced using an undisclosed block size of six."
- Source context preview: Screened patients were assigned a unique five-digit number. Randomized patients were additionally assigned a four-digit randomization number at baseline. Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six. The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency. --- The Neurological Assessment of Thioctic Acid in Diabetic Neuropathy (NATHAN) 1 trial was a multicenter (36 centers in the U.S., Canada, and Europe [Supplementary Materials]), randomized,...

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial is explicitly described as randomized double-blind with matching placebo tablets identical in appearance and appropriate emergency unblinding procedures; there is no indication blinding was likely broken or that lack of blinding would bias outcomes materially, so performance bias is judged low.
- Model support: Quote: "randomized, double-blind, placebo-controlled... film-coated tablets containing 600 mg ALA ... or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance"; "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency." Comment: Blinding of participants and study personnel was implemented with identical-appearing placebo and emergency sealed decoding envelopes. Probably done.
- GT support: Quote: "... matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance." Comment: trial described as double-blind.
- Source context preview: The Neurological Assessment of Thioctic Acid in Diabetic Neuropathy (NATHAN) 1 trial was a multicenter (36 centers in the U.S., Canada, and Europe [Supplementary Materials]), randomized, double-blind, placebo-controlled, two-arm, 1:1 allocation ratio, parallel-group clinical trial using film-coated tablets containing 600 mg ALA (Thioctacid HR; MEDA Pharma, Bad Homburg, Germany) that were administered once daily or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance in diabetic patients with mild-to-moderate DSPN (18). The trial consisted of a 2-week screening phase, 6-week placebo run-in phase, 4-year double-blind phase, and 4-week...

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial was explicitly double-blind with identical-appearing placebo and treatment tablets, and objective outcomes were assessed by trained personnel with central reading/quality assurance—making it unlikely that knowledge of allocation influenced outcome measurement (low risk of detection bias).
- Model support: Quote: "randomized, double-blind, placebo-controlled... film-coated tablets containing 600 mg ALA ... or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance"; "Experienced, trained, and certified (by P.J.D. and colleagues) physicians evaluated the NIS and NSC. The nerve conduction, quantitative sensory tests (QSTs), and autonomic tests were performed by trained and certified personnel (by P.A.L., W.J.L., P.J.D., and colleagues). All results were interactively evaluated by the Reading and Quality Assurance Centers (at Mayo Clinic and Health Partners)." Comment: Masking of participants and personnel was implemented and outcome assessments (clinical examinations, nerve conduction, QSTs, autonomic tests) were performed by trained/certified staff and centrally reviewed; blinding of outcome assessment was therefore probably maintained.
- GT support: Quote: "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency."
- Source context preview: The Neurological Assessment of Thioctic Acid in Diabetic Neuropathy (NATHAN) 1 trial was a multicenter (36 centers in the U.S., Canada, and Europe [Supplementary Materials]), randomized, double-blind, placebo-controlled, two-arm, 1:1 allocation ratio, parallel-group clinical trial using film-coated tablets containing 600 mg ALA (Thioctacid HR; MEDA Pharma, Bad Homburg, Germany) that were administered once daily or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance in diabetic patients with mild-to-moderate DSPN (18). The trial consisted of a 2-week screening phase, 6-week placebo run-in phase, 4-year double-blind phase, and 4-week...

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: High risk
- Match: False
- Model rationale: The report acknowledges expected high dropout and states intention-to-treat analysis was primary, but the article excerpts and extracted methods do not provide actual attrition rates, reasons, balance between groups, or how missing data were handled; this insufficient reporting prevents assessment of whether missing data could bias the results.
- Model support: Quote: "To account for a relatively high dropout rate expected in this long-term study, randomization of 250 patients per arm was proposed. Analysis of the intention-to-treat population was primary for all efficacy variables." Comment: Attrition details not reported in methods extraction ("Not reported"). No numbers or reasons for missing outcome data, balance between groups, or methods of handling missing data (imputation) are provided in the available excerpts. Probably not enough information to judge.
- GT support: More than 40% of participants discontinued intervention in both groups during the 4-year study. We do not know how many participants were lost before the outcomes at 2 years (our outcome of interest), and how many after the first 2 years. Most participants (454/460) were included in the ITT analysis, but the study authors did not report for how many they managed to measure the outcome, and for how many they used the last observation carried forward ("mean of weeks 191 and 192 or last available value after randomization"). Apparently, the proportion of dropouts and the causes of dropout were equally distributed among the 2 groups.
- Source context preview: We used a conservative approach to suggest that treatment with ALA may prevent worsening of DSPN but not necessarily cause improvement (16). A clinically meaningful treatment difference of 2.0 nds for the changes from baseline for NIS-LL+7 tests and statistical error probabilities α = 0.05 and β = 0.1 were assumed. Based on a two-sided t test, the following scenarios for SDs and sample size per group (n) were considered: SD 3.57, n = 68; SD 4, n = 86; SD 5, n = 133; SD 6, n = 191; SD 7, n = 211. To account for a relatively high dropout rate expected in this long-term study, randomization of 250 patients per arm was proposed. Analysis of the intention-to-treat population was primary for all...


## 22928960 - Houry 2012

- Mode: hybrid
- Article chars: 20317
- Extraction context chars: 12006
- Total seconds: 39.21

### Methodology Extraction

- `randomization_method`: We used computer-generated randomization to assign new reviewers to either the intervention or control group.
- `allocation_concealment_method`: Not reported
- `blinding_participants`: All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors.
- `blinding_personnel`: Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.
- `blinding_outcome_assessors`: Not reported
- `attrition_details`: Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown).
- `study_design`: Randomized controlled trial
- `additional_notes`: Participants were consecutive individuals newly added to our reviewer ranks during the study period. There were no exclusion criteria. Main outcomes were mean review quality rating score and slope in change in editor-assigned reviewer quality ratings; these were calculated from review scores recorded contemporaneously within our editorial management software. Data analysis used linear mixed effect models with Stata 10.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Unclear risk | Unclear risk | yes |  |
| Blinding of outcome assessment: All outcomes | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |
| Incomplete outcome data: All outcomes | Low risk | Low risk | yes |  |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The article explicitly states a computer-generated randomization method, which is a valid random component per Cochrane criteria, indicating low risk of bias from sequence generation.
- Model support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group." Comment: Probably done — the investigators explicitly report a computer-generated random sequence for allocation.
- GT support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group."
- Source context preview: We used computer-generated randomization to assign new reviewers to either the intervention or control group. A senior editor emailed those in the intervention group and invited them to participate in a new mentoring program. Once agreed, they were provided detailed instructions on how to proceed. Those in the control group received no initial study-specific contacts and no intervention beyond standard journal practices outlined above. Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups. --- For those who might think this lack of efficacy is aberrant or unique to our...

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: The study reports computer-generated randomization but gives no information on how allocations were concealed from those enrolling participants; without details (e.g. central randomization or sealed envelopes) concealment cannot be judged and thus is unclear risk.
- Model support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group." Comment: Allocation concealment method not reported. There is no description of central allocation, sealed envelopes, or other safeguards, so it is unclear whether those enrolling could foresee assignments (Probably not reported).
- GT support: Computer-generated randomization and only a senior editor was aware of who was to receive the intervention.
- Source context preview: For those who might think this lack of efficacy is aberrant or unique to our journal environment, similar results have been reported in regards to teaching physicians critical appraisal skills in other settings. A Cochrane review cited found only one randomized trial on teaching critical appraisal skills rigorous enough and stated that conclusions about the effects of teaching critical appraisal are debatable [18]. Another educational trial which randomized practitioners to half-day critical appraisal skills training workshop or wait list control found that those who took their course had a greater overall knowledge score, but no differences in overall attitude towards evidence, perceived...

#### Blinding of participants and personnel: All outcomes

- Prediction: Unclear risk
- Ground truth: Unclear risk
- Match: True
- Model rationale: Although editors invited reviewers without knowledge of allocation, participants in the mentorship arm were actively contacted and would know their status, and outcome ratings were editor-assigned with no clear blinding of assessors reported; this mixed information leaves the potential for performance bias unclear.
- Model support: Quote: "Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups." "All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors." Comment: Blinding of editors to group assignment during invitation appears to have been implemented (Probably done). However, participants (reviewers) in the intervention group were contacted and invited to participate in a mentoring program and thus were aware of their allocation; control group received no initial study-specific contacts. It is therefore probable that participants were not blinded (Probably not done). No explicit statement about...
- GT support: Quote: "Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups." Comment: personnel were blinded but unclear if participants were blinded.
- Source context preview: For those who might think this lack of efficacy is aberrant or unique to our journal environment, similar results have been reported in regards to teaching physicians critical appraisal skills in other settings. A Cochrane review cited found only one randomized trial on teaching critical appraisal skills rigorous enough and stated that conclusions about the effects of teaching critical appraisal are debatable [18]. Another educational trial which randomized practitioners to half-day critical appraisal skills training workshop or wait list control found that those who took their course had a greater overall knowledge score, but no differences in overall attitude towards evidence, perceived...

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: Editorial staff who generated the outcome scores were operating within a blinded peer-review process and invited reviewers without knowledge of allocation, so outcome assessment was unlikely to be influenced by knowledge of group assignment, meeting criteria for low risk of detection bias.
- Model support: Quote: "All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors." Comment: Probably done. Outcome measurements (editor-assigned reviewer quality ratings) were recorded contemporaneously within the editorial management software by editors who invited reviewers "in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups."
- GT support: Quote: "All reviews at Annals are routinely rated by editors for quality on a previously reported 5-point scale that has demonstrated moderate reliability and is comparable to the scale validated by van Rooyen." Comment: unclear if the editors were aware of allocation when assessing the reviews.
- Source context preview: Our main outcome measures were the mean review quality rating score for each reviewer, and the slope in change (improvement or deterioration) in editor-assigned reviewer quality ratings from their first review until the end date of the study. These were calculated from review scores recorded contemporaneously within our editorial management software. --- We hypothesized that perhaps these failures were due to an insufficiently focused and detailed mentoring process, which has been deemed necessary in previous studies of teaching complex writing skills [16]. We therefore attempted to develop a more individualized and detailed approach that would still not represent too great a burden on the...

#### Incomplete outcome data: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial reports the exact number and reason for the missing participants (four in the mentorship arm who did not receive the intervention), and an intention-to-treat analysis was conducted and reportedly yielded similar results, suggesting the missing data are unlikely to bias estimates materially. Thus attrition is low risk.
- Model support: Quote: "Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown). 37 reviewers returned the survey of their experience (17 controls and 20 mentees); of these all had had at least one category of prior training (see Table 1)." Comment: The authors report the number and reasons for missing intervention contact and state an ITT analysis was performed with essentially identical results (data not shown). Probably done: ITT analysis performed; missing data appear few and balanced and unlikely related to outcomes.
- GT support: Quote: "per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown)." Comment: 4 subjects in the intervention group did not receive the intervention and were excluded from the analysis. The researchers state that an ITT analysis "yielded essentially identical results" but the analyses are not included in the paper.
- Source context preview: Participant flow is shown in Figure 1. Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown). 37 reviewers returned the survey of their experience (17 controls and 20 mentees); of these all had had at least one category of prior training (see Table 1). --- We hypothesized that perhaps these failures were due to an insufficiently focused and detailed mentoring process, which has been...


## 23148458 - Sheridan 2012

- Mode: hybrid
- Article chars: 34179
- Extraction context chars: 12003
- Total seconds: 41.21

### Methodology Extraction

- `randomization_method`: Randomization used computer-generated random numbers that were sealed in opaque envelopes.
- `allocation_concealment_method`: Randomization used computer-generated random numbers that were sealed in opaque envelopes.
- `blinding_participants`: Not reported
- `blinding_personnel`: Not reported
- `blinding_outcome_assessors`: Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)
- `attrition_details`: Not reported
- `study_design`: Randomized controlled trial (two randomized controlled trials combined)
- `additional_notes`: Patients were randomized within practices. Interventions were delivered prior to scheduled appointments in a private room. Men in intervention groups watched informational videos and received a coaching session by a trained research assistant; men in the control viewed a highway safety video and received no coaching. Physicians completed baseline questionnaires.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Low risk | Low risk | yes |  |
| Blinding of participants and personnel: All outcomes | High risk | Low risk | no | blinding_outcome_type_or_role_confusion |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial report explicitly states randomization used computer-generated random numbers, which is a random method per Cochrane criteria, so risk of bias from sequence generation is low.
- Model support: Quote: "After providing informed consent and completing a baseline survey, eligible men were randomized within practices to receive one of the SDM interventions or a highway safety control video. Randomization used computer-generated random numbers that were sealed in opaque envelopes." Comment: Probably done — sequence generation used a computer random number generator (explicitly described).
- GT support: Randomisation used computer‐generated random numbers that were sealed in opaque envelopes.
- Source context preview: Between March 2005 and April 2006, we conducted two randomized controlled trials of the same prostate cancer screening intervention, alone or with additional information on two more clearly beneficial men’s health screening services (cardiovascular disease screening and colon cancer screening). We conducted each trial in a convenience sample from two practices (one academic and one community practice) within a single city (Chapel Hill, NC for the prostate only intervention and Greensboro, NC for the men’s health intervention). In both trials, we used the same educational video on highway safety (“Reducing Your Risk in a Crash” available at http://www.iihs.org/videos/default.html) as an...

#### Allocation concealment

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The authors report central procedures preventing foreknowledge: computer-generated random numbers and sealing allocations in opaque envelopes, which meets the criteria for adequate allocation concealment and makes selection bias unlikely.
- Model support: Quote: "Randomization used computer-generated random numbers that were sealed in opaque envelopes." Comment: Probably done — the study explicitly states allocation used computer-generated random numbers sealed in opaque envelopes, which is an accepted method to prevent foreknowledge of assignments.
- GT support: Randomisation used computer‐generated random numbers that were sealed in opaque envelopes.
- Source context preview: The patient intervention and accompanying surveys were delivered to participants prior to regularly scheduled medical appointments in a private room in each practice. After providing informed consent and completing a baseline survey, eligible men were randomized within practices to receive one of the SDM interventions or a highway safety control video. Randomization used computer-generated random numbers that were sealed in opaque envelopes. Men in the intervention groups watched one of our informational videos and then were guided through a coaching session by a trained research assistant. At the end of the coaching session, men were given a summary sheet of their opinions on prostate...

#### Blinding of participants and personnel: All outcomes

- Prediction: High risk
- Ground truth: Low risk
- Match: False
- Model rationale: The interventions (video + coaching vs control video) necessarily reveal group allocation to participants and research assistants, and personnel likely were unblinded; outcomes (patient-reported measures and interactions with physicians) are likely influenced by lack of blinding, so risk of performance bias is high.
- Model support: Quote: "Men in the intervention groups watched one of our informational videos and then were guided through a coaching session by a trained research assistant... After providing informed consent and completing a baseline survey, eligible men were randomized within practices to receive one of the SDM interventions or a highway safety control video. Randomization used computer-generated random numbers that were sealed in opaque envelopes." Comment: Blinding of participants and personnel is not reported and is implausible given that intervention involved watching an informational video plus coaching versus a control video with no coaching. Physicians saw patients from both groups (risk of contamination). Probably not done — participants and those delivering the intervention were aware of group assignment.
- GT support: "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)." Although described as single‐masked in the study registration, due to the attention control intervention in the control groups, both participants and staff could be considered blinded.
- Source context preview: Between March 2005 and April 2006, we conducted two randomized controlled trials of the same prostate cancer screening intervention, alone or with additional information on two more clearly beneficial men’s health screening services (cardiovascular disease screening and colon cancer screening). We conducted each trial in a convenience sample from two practices (one academic and one community practice) within a single city (Chapel Hill, NC for the prostate only intervention and Greensboro, NC for the men’s health intervention). In both trials, we used the same educational video on highway safety (“Reducing Your Risk in a Crash” available at http://www.iihs.org/videos/default.html) as an...

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The study explicitly states physicians were not informed of group assignments, reducing risk that assessors' knowledge biased outcome measurement; outcomes (patient-reported knowledge, participation, and screening decisions) are less likely to be materially influenced by assessor awareness given this concealment.
- Model support: Quote: "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)" Comment: Blinding of outcome assessment (physicians who assessed outcomes and/or influenced decisions) was probably achieved because physicians were not told participants' group assignment; therefore assessment and recording of outcomes is unlikely to have been influenced by knowledge of allocation. Probably done.
- GT support: Self‐reported outcome measures, therefore, low risk considering masking of participants.
- Source context preview: Between March 2005 and April 2006, we conducted two randomized controlled trials of the same prostate cancer screening intervention, alone or with additional information on two more clearly beneficial men’s health screening services (cardiovascular disease screening and colon cancer screening). We conducted each trial in a convenience sample from two practices (one academic and one community practice) within a single city (Chapel Hill, NC for the prostate only intervention and Greensboro, NC for the men’s health intervention). In both trials, we used the same educational video on highway safety (“Reducing Your Risk in a Crash” available at http://www.iihs.org/videos/default.html) as an...

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Because the report does not provide information on amount, balance, reasons, or handling (imputation) of missing outcome data, we cannot determine whether missing data are unlikely to bias results or are likely to induce bias; thus the risk of attrition bias is unclear.
- Model support: Quote: "attrition_details: Not reported" Comment: The article excerpts and extracted methods do not report numbers lost to follow-up, reasons for missing data, or how missing data were handled for outcomes (e.g. survey responses or 9-month chart review). Therefore there is insufficient information to judge whether missing outcome data could bias results. Probably not done: no explicit reporting of attrition or imputation was found.
- GT support: SeeFigure 1for reporting on missing data (only 2 participants in intervention group due to false inclusion)
- Source context preview: Between March 2005 and April 2006, we conducted two randomized controlled trials of the same prostate cancer screening intervention, alone or with additional information on two more clearly beneficial men’s health screening services (cardiovascular disease screening and colon cancer screening). We conducted each trial in a convenience sample from two practices (one academic and one community practice) within a single city (Chapel Hill, NC for the prostate only intervention and Greensboro, NC for the men’s health intervention). In both trials, we used the same educational video on highway safety (“Reducing Your Risk in a Crash” available at http://www.iihs.org/videos/default.html) as an...

## Workflow Evolution Notes

- Inspect mismatches where prediction is `Unclear risk` but GT is `Low risk`: these usually mean retrieval or Stage 1 extraction missed a concrete methodological phrase.
- Inspect mismatches where prediction is `Low risk` or `High risk` but GT is `Unclear risk`: these usually mean the prompt is allowing too much inference from generic trial language.
- For blinding mismatches, add outcome-type cues to the prompt: self-report outcomes, objective outcomes, assessor-administered outcomes, and whether lack of blinding can materially affect the outcome.
- For allocation concealment mismatches, require the model to distinguish sequence generation from concealment before assignment.